Royalty Pharma plc generated $2.4B in revenue in fiscal year 2025. This represents an increase of 5.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $2.5B in revenue. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Royalty Pharma plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RPRX Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
RPRX Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Royalty Pharma plc financials
Frequently Asked Questions
What was Royalty Pharma plc's revenue in fiscal year 2025?
Royalty Pharma plc generated $2.4B in revenue in fiscal year 2025.
How fast is Royalty Pharma plc's revenue growing?
Royalty Pharma plc (RPRX) revenue rose by 5.1% year over year, from $2.3B to $2.4B in fiscal year 2025.
What is Royalty Pharma plc's revenue over the last twelve months?
Royalty Pharma plc (RPRX) reported $2.5B in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Royalty Pharma plc's revenue changed over the years?
Across the 8 fiscal years this page covers, Royalty Pharma plc (RPRX) revenue went from $1.8B in fiscal year 2018 to $2.4B in fiscal year 2025.
What was Royalty Pharma plc's revenue in the most recent quarter?
Royalty Pharma plc (RPRX) reported $674.1M in revenue in Q2 2026. This represents an increase of 16.5% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Royalty Pharma plc (RPRX) reported on that line in every period on record.